Jindong Chen earned his Ph.D. from the Karolinska Institute, Sweden. He is an active member of the American Association for Cancer Research (AACR) and the chief technology officer at Exploring Health, LLC. He is also a professor at Zunyi Medical University, China, and a former research associate professor and kidney laboratory co-director at the University of Rochester Medical Center, USA. When serving as a research scientist at Van Andel Research Institute, USA, and a senior scientist at the National Cancer Center Singapore and Duke-NUS University Medical School, USA, Dr. Chen position-cloned two cancer-related genes, NORE1 and LSAMP, and participated in the identification of HRPT2 and FLCN. He subsequently developed several FLCN and HRPT2 knockout mouse models. For those achievements, he was awarded at the 94th and 100th AACR annual meetings. Currently, Dr. Chen is working on the development of anti-metastasis drugs.